Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26,644 INR | 0.00% | +1.04% | +16.59% |
05-10 | Abbott India's Net Profit Climbs in Fiscal Q4; Shares Up 3% | MT |
05-09 | Drugmaker Abbott India posts Q4 profit rise on higher sales | RE |
Sales 2024 | 58.49B 702M 958M | Sales 2025 * | 64.7B 777M 1.06B | Capitalization | 566B 6.8B 9.27B |
---|---|---|---|---|---|
Net income 2024 | 12.01B 144M 197M | Net income 2025 * | 13.12B 158M 215M | EV / Sales 2024 | 9.79 x |
Net cash position 2024 * | 22.66B 272M 371M | Net cash position 2025 * | 21.47B 258M 351M | EV / Sales 2025 * | 8.42 x |
P/E ratio 2024 |
47.7
x | P/E ratio 2025 * |
43.1
x | Employees | 3,700 |
Yield 2024 * |
1.1% | Yield 2025 * |
1.34% | Free-Float | 24.52% |
1 week | +1.04% | ||
Current month | +0.86% | ||
1 month | +1.96% | ||
3 months | -9.80% | ||
6 months | +12.98% | ||
Current year | +16.59% |
Managers | Title | Age | Since |
---|---|---|---|
Swati Dalal
CEO | Chief Executive Officer | - | 94-12-31 |
Director of Finance/CFO | - | - | |
Jejoe Karankumar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 19-03-31 | |
Chairman | 81 | 67-12-31 | |
Director/Board Member | 67 | 95-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-18 | 26,644 | +0.58% | 47 |
24-05-17 | 26,490 | -0.21% | 338 |
24-05-16 | 26,545 | +0.42% | 391 |
24-05-15 | 26,434 | -1.31% | 535 |
24-05-14 | 26,784 | -0.96% | 307 |
Delayed Quote Bombay S.E., May 18, 2024 at 03:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.59% | 6.8B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.74% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- ABBOTINDIA Stock